TABLE 1.

Clinical details of 10 neonates with Lodderomyces elongisporus fungemia in a neonatal intensive care unit, India^a

Patient	Isolate ID	DOB/DOA (day-mo-yr)	Date of blood culture (day-mo-yr)	Clinical details	Outcome	Antifungal therapy
1	906-P-21	07-09-2021	16-09-2021	PT, VLBW, thrombocytopenia	Survived	FLU and AMB
2	950-P-21	02-09-2021	24-09-2021	PT, IUGR, thrombocytopenia	Survived	FLU and AMB
3	963-P-21	18-09-2021	28-09-2021	PT, VLBW, severe asphyxia	Survived	FLU and AMB
	979-P-21-S62		30-09-2021
	979-P-21-S87		19-10-2021
	1023-P-21		28-10-2021
4	972-P-21	17-09-2021	30-09-2021	PT, ELBW, thrombocytopenia, hypoglycemia	Survived	FLU and AMB
5	1003-P-21	24-09-2021	12-10-2021	Term, hypoglycemia, thrombocytopenia	Survived	FLU and AMB
6	1107-P-21	01-11-2021	16-11-2021	LBW, PT, thrombocytopenia	Survived	FLU and AMB
7	89-P-22	2-01-2022	31-01-2022	VLBW, PT	Died	FLU and AMB
8	144-P-22	01-02-2022	07-02-2022	Term, LBW, sepsis, thrombocytopenia	Survived	FLU and AMB
9	147-P-22	03-02-2022	09-02-2022	VLBW, severe asphyxia at birth	Survived	FLU and AMB
10	160-P-22	12-02-2022	21-02-2022	VLBW, PT	Survived	FLU and AMB

^aID, identifier; DOA, date of admission; DOB, date of birth; VLBW, very low birthweight; IUGR, intrauterine growth restriction; PT, preterm; ELBW, extremely low birthweight; LBW, low birthweight; FLU, fluconazole; AMB; amphotericin B.